Know Labs, Inc., now reflected in SEC filings as USBC, Inc., reports developments tied to its completed control transaction, digital-asset treasury strategy and continuing diagnostic-technology work. Recent updates include the company's shift toward the USBC token, a digital U.S. dollar product using blockchain and digital identity, alongside governance, shareholder voting and capital-structure actions.
The company's legacy research division continues work on Radio Frequency Dielectric Spectroscopy (RFDS), a spectroscopy platform designed to capture molecular signatures in wearable, mobile or bench-top formats. News also covers non-invasive analyte monitoring, pH detection research, a planned non-invasive glucose-monitor application requiring FDA clearance, licensing activity through Know Labs Technology Licensing and public-company status changes.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.